SCHEMBL14919304

SCHEMBL14919304

Cc1ccc(Cl)cc1-c1ccc(CC(CC(O)C(=O)O)NC(=O)C(=O)O)cc1

nearest known ligand 0.68

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.68
▸ ACE P12821 15/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14891853 1.00 MME (0.68) MMEACE
SCHEMBL14890559 0.91 MME (0.61) MMEACE
SCHEMBL14890537 0.89 MME (0.73) MMEACE
SCHEMBL14891285 0.89 MME (0.71) MMEACE
SCHEMBL18598045 0.89 MME (0.71) MMEACE
SCHEMBL14890847 0.88 MME (0.74) MMEACE
SCHEMBL14890644 0.88 MME (0.69) MMEACE
SCHEMBL14890631 0.82 MME (0.60) MMEACE
SCHEMBL18597868 0.81 MME (1.00) MMEACE
SCHEMBL14890447 0.81 MME (1.00) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773335-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2014-09-10 — — EP disclosed
WO-2013067163-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2013-05-10 — — WO disclosed
Send feedback